Stifel Financial
GILD icon

Stifel Financial’s Gilead Sciences GILD Stock Holding History

Stifel Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300
Closed -$31K – 2343
2014
Q4 		$31K Hold
300
– – ﹤0.01% 2236
2014
Q3 		$34K Hold
300
– – ﹤0.01% 2167
2014
Q2 		$27K Buy
+300
New +$23.4K ﹤0.01% 2166

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stifel Financial's GILD Position: Q2 2026 in Review

Stifel Financial reduced its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, selling an estimated $6.56M and leaving 1,152,519 shares worth $146M. The position accounts for 0.12% of the portfolio, ranked #188.

Stifel Financial first reported a position in GILD in Q1 2014 and has held it in 50 quarters since. The position peaked at $170M in Q4 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Stifel Financial held 1,152,519 shares of Gilead Sciences worth $146M as of Q2 2026.
  • Stifel Financial sold 49,802 Gilead Sciences shares in Q2 2026, an estimated $6.56M.
  • Gilead Sciences made up 0.12% of Stifel Financial's portfolio in Q2 2026, its #188 holding.
  • Stifel Financial first reported a position in Gilead Sciences in Q1 2014 and has held it in 50 quarters since.
  • Stifel Financial's Gilead Sciences position peaked at $170M in Q4 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.